Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
P 1 (3)

Trial Status

Recruiting2
Not Yet Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07088588Phase 1Not Yet Recruiting

Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors

NCT06666270Phase 1Recruiting

Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors

NCT06525298Phase 1Recruiting

EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors

Showing all 3 trials

Research Network

Activity Timeline